Close Menu

In Newsweek, George Church writes that the message that people get from knowing their genomes "is not 'Here's your destiny. Get used to it!' Instead, it's 'Here's your destiny, and you can do something about it!'" Though pharmacogenomics is in its early days, Church points out that it is already being used to help patients. Furthermore, he adds that cheaper genomics will not only change the course of biological research, but also bestow benefits upon the public as a whole.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.